{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T14:06:09Z","timestamp":1791295569132,"version":"4.1.0"},"reference-count":33,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2014,1,1]],"date-time":"2014-01-01T00:00:00Z","timestamp":1388534400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Cardiac Failure"],"published-print":{"date-parts":[[2014,1]]},"DOI":"10.1016\/j.cardfail.2013.11.011","type":"journal-article","created":{"date-parts":[[2013,12,1]],"date-time":"2013-12-01T17:46:40Z","timestamp":1385920000000},"page":"38-44","source":"Crossref","is-referenced-by-count":29,"title":["Relationship Between Galectin-3 Levels and Mineralocorticoid Receptor Antagonist Use in Heart Failure: Analysis From HF-ACTION"],"prefix":"10.1016","volume":"20","author":[{"given":"Mona","family":"Fiuzat","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Phillip J.","family":"Schulte","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Felker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tariq","family":"Ahmad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Megan","family":"Neely","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kirkwood F.","family":"Adams","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark P.","family":"Donahue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William E.","family":"Kraus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ileana L.","family":"Pi\u00f1a","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David J.","family":"Whellan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher M.","family":"O\u2019Connor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cardfail.2013.11.011_bib1","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1093\/eurjhf\/hfp097","article-title":"Galectin-3: A novel mediator of heart failure development and progression","volume":"11","author":"de Boer","year":"2009","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.cardfail.2013.11.011_bib2","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1161\/CIRCHEARTFAILURE.111.963637","article-title":"Galectin-3 in ambulatory patients with heart failure: Results from the hf-action study","volume":"5","author":"Felker","year":"2012","journal-title":"Circ Heart Fail"},{"key":"10.1016\/j.cardfail.2013.11.011_bib3","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1016\/j.ahj.2012.08.021","article-title":"The predictive value of galectin-3 for mortality and cardiovascular events in the Controlled Rosuvastatin Multinational Trial in Heart Failure (CORONA)","volume":"164","author":"Gullestad","year":"2012","journal-title":"Am Heart J"},{"key":"10.1016\/j.cardfail.2013.11.011_bib4","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1016\/j.jacc.2012.04.053","article-title":"Galectin-3, a marker of cardiac fibrosis, predicts incident heart failure in the community","volume":"60","author":"Ho","year":"2012","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.cardfail.2013.11.011_bib5","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1016\/S0735-1097(01)01539-X","article-title":"Relationship between transcardiac extraction of aldosterone and left ventricular remodeling in patients with first acute myocardial infarction: extracting aldosterone through the heart promotes ventricular remodeling after acute myocardial infarction","volume":"38","author":"Hayashi","year":"2001","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.cardfail.2013.11.011_bib6","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1161\/ATVBAHA.112.300569","article-title":"Galectin-3 mediates aldosterone-induced vascular fibrosis","volume":"33","author":"Calvier","year":"2013","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.cardfail.2013.11.011_bib7","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1056\/NEJMoa030207","article-title":"Eplerenone Post-Acute Myocardial Infarction Heart Failure E, Survival Study I. Eplerenone, a selective aldosterone blocker, in patients with left ventricular dysfunction after myocardial infarction","volume":"348","author":"Pitt","year":"2003","journal-title":"N Engl J Med"},{"key":"10.1016\/j.cardfail.2013.11.011_bib8","doi-asserted-by":"crossref","first-page":"2097","DOI":"10.1001\/jama.2012.14795","article-title":"Associations between aldosterone antagonist therapy and risks of mortality and readmission among patients with heart failure and reduced ejection fraction","volume":"308","author":"Hernandez","year":"2012","journal-title":"JAMA"},{"key":"10.1016\/j.cardfail.2013.11.011_bib9","doi-asserted-by":"crossref","first-page":"e004374","DOI":"10.1161\/JAHA.112.004374","article-title":"Galectin-3 in heart failure: more answers or more questions?","volume":"1","author":"Ahmad","year":"2012","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.cardfail.2013.11.011_bib10","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1093\/eurjhf\/hfq091","article-title":"Galectin-3, cardiac structure and function, and long-term mortality in patients with acutely decompensated heart failure","volume":"12","author":"Shah","year":"2010","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.cardfail.2013.11.011_bib11","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1038\/clpt.2013.139","article-title":"Therapeutic implications of biomarkers in chronic heart failure","volume":"94","author":"Ahmad","year":"2013","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.cardfail.2013.11.011_bib12","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1161\/HYPERTENSIONAHA.111.190512","article-title":"Aldosterone inhibits antifibrotic factors in mouse hypertensive heart","volume":"59","author":"Azibani","year":"2012","journal-title":"Hypertension"},{"key":"10.1016\/j.cardfail.2013.11.011_bib13","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1161\/CIRCHEARTFAILURE.112.000146","article-title":"Galectin-3 and cardiac function in survivors of acute myocardial infarction","volume":"6","author":"Weir","year":"2013","journal-title":"Circ Heart Fail"},{"key":"10.1016\/j.cardfail.2013.11.011_bib14","doi-asserted-by":"crossref","first-page":"2290","DOI":"10.1093\/eurheartj\/ehs077","article-title":"Galectin-3 predicts response to statin therapy in the Controlled Rosuvastatin Multinational Trial in Heart Failure (CORONA)","volume":"33","author":"Gullestad","year":"2012","journal-title":"Eur Heart J"},{"key":"10.1016\/j.cardfail.2013.11.011_bib15","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1001\/jama.2009.454","article-title":"Efficacy and safety of exercise training in patients with chronic heart failure: HF-ACTION randomized controlled trial","volume":"301","author":"O\u2019Connor","year":"2009","journal-title":"JAMA"},{"key":"10.1016\/j.cardfail.2013.11.011_bib16","doi-asserted-by":"crossref","first-page":"e391","DOI":"10.1161\/CIRCULATIONAHA.109.192065","volume":"119","author":"Hunt","year":"2009","journal-title":"Circulation"},{"key":"10.1016\/j.cardfail.2013.11.011_bib17","doi-asserted-by":"crossref","first-page":"1977","DOI":"10.1161\/CIRCULATIONAHA.109.192064","volume":"119","author":"Jessup","year":"2009","journal-title":"Circulation"},{"key":"10.1016\/j.cardfail.2013.11.011_bib18","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1161\/CIRCHEARTFAILURE.111.963462","article-title":"Factors related to morbidity and mortality in patients with chronic heart failure with systolic dysfunction: the HF-ACTION predictive risk score model","volume":"5","author":"O\u2019Connor","year":"2012","journal-title":"Circ Heart Fail"},{"key":"10.1016\/j.cardfail.2013.11.011_bib19","doi-asserted-by":"crossref","first-page":"3083","DOI":"10.1002\/sim.3697","article-title":"Balance diagnostics for comparing the distribution of baseline covariates between treatment groups in propensity-score matched samples","volume":"28","author":"Austin","year":"2009","journal-title":"Stat Med"},{"key":"10.1016\/j.cardfail.2013.11.011_bib20","doi-asserted-by":"crossref","first-page":"3121","DOI":"10.1161\/01.CIR.0000147181.65298.4D","article-title":"Galectin-3 marks activated macrophages in failure-prone hypertrophied hearts and contributes to cardiac dysfunction","volume":"110","author":"Sharma","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.cardfail.2013.11.011_bib21","first-page":"361","article-title":"Galectin-3 in heart failure: high levels are associated with all-cause mortality","volume":"150","author":"Ueland","year":"2011","journal-title":"In J Cardiol"},{"key":"10.1016\/j.cardfail.2013.11.011_bib22","doi-asserted-by":"crossref","first-page":"60","DOI":"10.3109\/07853890.2010.538080","article-title":"Predictive value of plasma galectin-3 levels in heart failure with reduced and preserved ejection fraction","volume":"43","author":"de Boer","year":"2011","journal-title":"Ann Med"},{"key":"10.1016\/j.cardfail.2013.11.011_bib23","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1007\/s00392-010-0125-y","article-title":"Prognostic value of galectin-3, a novel marker of fibrosis, in patients with chronic heart failure: data from the DEAL-HF study","volume":"99","author":"Lok","year":"2010","journal-title":"Clin Res Cardiol"},{"key":"10.1016\/j.cardfail.2013.11.011_bib24","doi-asserted-by":"crossref","first-page":"e58","DOI":"10.1161\/CIRCHEARTFAILURE.113.000382","article-title":"Response to letter regarding article, \u201cGalectin-3 and Cardiac Function in Survivors of Acute Myocardial Infarction.\u201d","volume":"6","author":"Weir","year":"2013","journal-title":"Circ Heart Fail"},{"key":"10.1016\/j.cardfail.2013.11.011_bib25","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1093\/eurjhf\/hfs205","article-title":"Baseline and serial measurements of galectin-3 in patients with heart failure: relationship to prognosis and effect of treatment with valsartan in the VAL-HEFT","volume":"15","author":"Anand","year":"2013","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.cardfail.2013.11.011_bib26","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1056\/NEJMoa1009492","article-title":"Group E-HS. Eplerenone in patients with systolic heart failure and mild symptoms","volume":"364","author":"Zannad","year":"2011","journal-title":"N Engl J Med"},{"key":"10.1016\/j.cardfail.2013.11.011_bib27","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1056\/NEJM199909023411001","article-title":"Randomized Aldactone Evaluation Study Investigators. The effect of spironolactone on morbidity and mortality in patients with severe heart failure","volume":"341","author":"Pitt","year":"1999","journal-title":"N Engl J Med"},{"key":"10.1016\/j.cardfail.2013.11.011_bib28","doi-asserted-by":"crossref","first-page":"1658","DOI":"10.1001\/jama.2009.1493","article-title":"Use of aldosterone antagonists in heart failure","volume":"302","author":"Albert","year":"2009","journal-title":"JAMA"},{"key":"10.1016\/j.cardfail.2013.11.011_bib29","doi-asserted-by":"crossref","first-page":"12A","DOI":"10.1016\/0002-9149(93)90239-9","article-title":"Antifibrotic effects of spironolactone in preventing myocardial fibrosis in systemic arterial hypertension","volume":"71","author":"Brilla","year":"1993","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.cardfail.2013.11.011_bib30","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1161\/JAHA.111.000018","article-title":"Incremental reduction in risk of death associated with use of guideline-recommended therapies in patients with heart failure: a nested case-control analysis of IMPROVE HF","volume":"1","author":"Fonarow","year":"2012","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.cardfail.2013.11.011_bib31","doi-asserted-by":"crossref","first-page":"1156","DOI":"10.1016\/j.ahj.2010.08.036","article-title":"Spironolactone use at discharge was associated with improved survival in hospitalized patients with systolic heart failure","volume":"160","author":"Hamaguchi","year":"2010","journal-title":"Am Heart J"},{"key":"10.1016\/j.cardfail.2013.11.011_bib32","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1111\/j.1527-5299.2006.05502.x","article-title":"Racial differences in potassium response to spironolactone in heart failure","volume":"12","author":"Cavallari","year":"2006","journal-title":"Congest Heart Fail"},{"key":"10.1016\/j.cardfail.2013.11.011_bib33","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1161\/01.HYP.23.2.179","article-title":"Regulation of aldosterone secretion in hypertensive blacks","volume":"23","author":"Fisher","year":"1994","journal-title":"Hypertension"}],"container-title":["Journal of Cardiac Failure"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S107191641301261X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S107191641301261X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,10,8]],"date-time":"2018-10-08T11:51:30Z","timestamp":1538999490000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S107191641301261X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,1]]},"references-count":33,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2014,1]]}},"alternative-id":["S107191641301261X"],"URL":"https:\/\/doi.org\/10.1016\/j.cardfail.2013.11.011","relation":{},"ISSN":["1071-9164"],"issn-type":[{"value":"1071-9164","type":"print"}],"subject":[],"published":{"date-parts":[[2014,1]]}}}